{"filing":{"accession_number":"0001213900-26-070229","cik":"0001912966","ticker":"RGNT","company_name":"REGENTIS BIOMATERIALS LTD.","form":"6-K","filing_date":"2026-06-18","report_date":null,"primary_document":"ea0295232-6k_regentis.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1912966/000121390026070229/ea0295232-6k_regentis.htm"},"events":[{"id":12104,"run_id":10667,"accession_number":"0001213900-26-070229","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The press release announces a private placement of $6.5 million in ordinary shares (or pre-funded warrants) and ordinary warrants to accredited and institutional investors under Section 4(a)(2) and Regulation D exemptions. This is an unregistered equity issuance that will dilute existing shareholders, with 1,857,143 ordinary shares and accompanying warrants being issued at $3.50 per share. The company explicitly states it has entered into definitive securities purchase agreements and expects closing on June 23, 2026.","company_name":"REGENTIS BIOMATERIALS LTD.","ticker":"RGNT","filing_date":"2026-06-18","form":"6-K","submitted_at":null,"items":[{"id":8864,"accession_number":"0001213900-26-070229","item_number":"EX-99.1","item_title":"ea029523201ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The press release announces a private placement of $6.5 million in ordinary shares (or pre-funded warrants) and ordinary warrants to accredited and institutional investors under Section 4(a)(2) and Regulation D exemptions. This is an unregistered equity issuance that will dilute existing shareholders, with 1,857,143 ordinary shares and accompanying warrants being issued at $3.50 per share. The company explicitly states it has entered into definitive securities purchase agreements and expects closing on June 23, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-08fd3440","taxonomy_version":"v1.2","classified_at":"2026-06-21T19:03:10.781397+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8864,"accession_number":"0001213900-26-070229","item_number":"EX-99.1","item_title":"ea029523201ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The press release announces a private placement of $6.5 million in ordinary shares (or pre-funded warrants) and ordinary warrants to accredited and institutional investors under Section 4(a)(2) and Regulation D exemptions. This is an unregistered equity issuance that will dilute existing shareholders, with 1,857,143 ordinary shares and accompanying warrants being issued at $3.50 per share. The company explicitly states it has entered into definitive securities purchase agreements and expects closing on June 23, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-08fd3440","taxonomy_version":"v1.2","classified_at":"2026-06-21T19:03:10.781397+00:00","company_name":"REGENTIS BIOMATERIALS LTD.","ticker":"RGNT","filing_date":"2026-06-18"}]}